• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特比萘芬治疗足趾甲真菌病。足部是否更接近指甲治愈的理想状态?

Terbinafine for the treatment of pedal onychomycosis. A foot closer to the promised land of cured nails?

作者信息

Shear N H, Gupta A K

机构信息

Division of Dermatology, Sunnybrook Health Science Center, Ontario.

出版信息

Arch Dermatol. 1995 Aug;131(8):937-42.

PMID:7632066
Abstract

Onychomycosis of the nails includes fungal infection caused by primary nail pathogens that invade the healthy nail plate and secondary invasion in nails with preexisting disease. Onychomycosis may be due to secondary infection from tinea pedis and is the most common nail disease, accounting for roughly 30% of all cutaneous fungal infections. In a survey of 9332 British adults, 16 years of age and older, the prevalence of dermatophyte infection was 2.6% to 2.8%. In subjects 55 years of age or older, the prevalence was 4.7%. In the United States, a similar prevalence has been reported. Onychomycosis can have a significant psychological effect on the subject. In a North American study, the relative composition of isolates from nails was dermatophytes (91%), yeasts (5%), and molds (4%). Candida is isolated predominantly from fingernails. Uncommonly, there are mixed infections. In other parts of the world, the frequency of these agents may vary.

摘要

甲癣包括由原发性甲病原体引起的真菌感染,这些病原体侵入健康的甲板,以及在已有疾病的指甲中继发感染。甲癣可能是足癣继发感染所致,是最常见的指甲疾病,约占所有皮肤真菌感染的30%。在一项对9332名16岁及以上英国成年人的调查中,皮肤癣菌感染的患病率为2.6%至2.8%。在55岁及以上的人群中,患病率为4.7%。在美国,也报告了类似的患病率。甲癣会对患者产生重大的心理影响。在一项北美研究中,从指甲分离出的菌株相对组成是皮肤癣菌(91%)、酵母菌(5%)和霉菌(4%)。念珠菌主要从指甲中分离出来。罕见的情况下会有混合感染。在世界其他地区,这些病原体的频率可能有所不同。

相似文献

1
Terbinafine for the treatment of pedal onychomycosis. A foot closer to the promised land of cured nails?特比萘芬治疗足趾甲真菌病。足部是否更接近指甲治愈的理想状态?
Arch Dermatol. 1995 Aug;131(8):937-42.
2
Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.特比萘芬和伊曲康唑治疗老年人皮肤癣菌性 toenail 甲真菌病的单盲、随机、前瞻性研究。 (注:这里“toenail”结合语境应是指趾甲,但表述稍显奇怪,可能原文有误,正常应该是“toenail onychomycosis”即趾甲甲真菌病)
J Am Acad Dermatol. 2001 Mar;44(3):479-84. doi: 10.1067/mjd.2001.110874.
3
Non-dermatophytes in onychomycosis of the toenails.非皮肤癣菌与趾甲甲真菌病
Br J Dermatol. 1997 Apr;136(4):490-3.
4
Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.口服特比萘芬治疗甲癣的安全性和有效性:在开放性随机试验“改善甲癣治疗结果——特比萘芬与清创术联用(IRON-CLAD)”中老年亚组分析
Am J Geriatr Pharmacother. 2006 Mar;4(1):1-13. doi: 10.1016/j.amjopharm.2005.12.012.
5
The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial.银屑病患者甲癣的患病率、病原体及治疗:一项前瞻性对照试验。
Clin Exp Dermatol. 2007 Jan;32(1):1-5. doi: 10.1111/j.1365-2230.2006.02215.x. Epub 2006 Jul 4.
6
Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections.特比萘芬治疗甲真菌病:对其在高危人群及非皮肤癣菌感染患者中疗效的综述
Br J Dermatol. 2004 Mar;150(3):414-20. doi: 10.1046/j.1365-2133.2003.05726.x.
7
Management of onychomycosis in children.儿童甲癣的治疗
Postgrad Med. 1999 Jul;Spec No:31-7.
8
Diagnosing and treating onychomycosis.诊断和治疗甲癣
J Fam Pract. 1996 May;42(5):513-8.
9
[Antimycotic therapy of Tinea unguium and other onychomycoses].[甲癣及其他甲真菌病的抗真菌治疗]
Med Monatsschr Pharm. 2009 Aug;32(8):289-98; quiz 299-300.
10
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.甲真菌病对系统用特比萘芬和唑类药物治疗不敏感,表明其感染因子是非皮肤癣菌霉菌。
Dermatology. 2010;220(2):164-8. doi: 10.1159/000277762. Epub 2010 Jan 29.

引用本文的文献

1
Pharmacokinetics of antifungal agents in onychomycoses.抗真菌药物在甲癣中的药代动力学。
Clin Pharmacokinet. 2001;40(6):441-72. doi: 10.2165/00003088-200140060-00005.
2
Onychomycosis in the elderly.老年人甲癣
Drugs Aging. 2000 Jun;16(6):397-407. doi: 10.2165/00002512-200016060-00002.
3
A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.用于治疗甲癣的新型口服抗真菌药物的风险效益评估。
Drug Saf. 2000 Jan;22(1):33-52. doi: 10.2165/00002018-200022010-00004.
4
Management of onychomycoses.甲癣的治疗
Drugs. 1999 Aug;58(2):283-96. doi: 10.2165/00003495-199958020-00005.
5
An overview of topical antifungal therapy in dermatomycoses. A North American perspective.皮肤真菌病的局部抗真菌治疗概述。北美视角。
Drugs. 1998 May;55(5):645-74. doi: 10.2165/00003495-199855050-00004.
6
Onychomycosis. Going for cure.甲癣。寻求治愈。
Can Fam Physician. 1997 Feb;43:299-305.
7
Onychomycosis. New therapies for an old disease.甲癣。古老疾病的新疗法。
West J Med. 1996 Dec;165(6):349-51.